AGL - NYSE
Agilon Health, Inc.
$82.70
-11%agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
At a Glance
Live SnapshotAgilon Health, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Negative gross margin indicates the company is losing money on each sale—unsustainable long-term.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Critical situation: Negative gross margins indicate fundamental business model issues. The company loses money on every sale—immediate strategic changes required.
Agilon Health, Inc. Income Statement
AGL • NYSE
| Agilon Health, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
REVENUE | |||||||
5.9B | 6.1B | 4.3B | 2.4B | 1.5B | 1.2B | 794.4M | |
GROSS PROFIT | |||||||
(6.1B) | (6.1B) | (4.2B) | (2.3B) | (1.5B) | (1.1B) | (765.9M) | |
-188.6M | 4.8M | 69.7M | 111.4M | 65.7M | 94.2M | 28.5M | |
OPERATING INCOME | |||||||
(232.5M) | (297M) | (301.8M) | (216.7M) | (438M) | (150.8M) | (135.1M) | |
(238.5M) | (268.9M) | (285.8M) | (207.8M) | (427.5M) | (137.3M) | (122.8M) | |
-421.1M | -292.1M | -232.1M | -105.4M | -372.2M | -56.7M | -106.6M | |
PRE-TAX INCOME | |||||||
(6.6M) | (6.2M) | (6.7M) | (4.5M) | (6.1M) | (8.1M) | (9.1M) | |
-6.6M | -6.2M | -6.7M | -4.5M | -6.1M | -8.1M | -9.1M | |
-6.1M | (28.1M) | (16M) | (8.9M) | (10.5M) | (13.5M) | (12.3M) | |
17M | 43.3M | 37.7M | 14.7M | -10.7M | -5.7M | -8.1M | |
-404.1M | -248.8M | -194.5M | -90.7M | -383M | -62.3M | -114.7M | |
NET INCOME | |||||||
(1.3M) | (1.5M) | (791K) | (1.6M) | (886K) | (865K) | -232K | |
-405.3M | -260.2M | -262.6M | -106.6M | -406.5M | -60.1M | -114.5M |
SEC Filings
AGL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 03, 2026 | June 02, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 06, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 27, 2026 | April 24, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 02, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 30, 2026 | March 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 18, 2026 | March 17, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 25, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 25, 2026 | February 25, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | February 18, 2026 | March 17, 2026 | 2026 |
Related Guides
Continue your AGL research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.